FOLR1 and neoplasm: Therefore, we hypothesized that MORAb-202 specifically inhibits cell proliferation and tumor growth in FOLR1-positive cells, and its effect on cell cycle distribution is similar to that of eribulin, which is a payload of MORAb-202.